Follow the 이노진 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 이노진 has recorded 1 insider filings. Market capitalisation: €13.2bn. The latest transaction was reported on 8 April 2026 (Sale). Among the most active insiders: ANTONIUS RACHMAT SOELISTYO. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
이노진 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于开发疾病治疗的创新解决方案。